Alex Goldfarb
Stock Analyst at Piper Sandler
(2.56)
# 2,265
Out of 4,761 analysts
15
Total ratings
66.67%
Success rate
11.19%
Average return
Main Sectors:
Stocks Rated by Alex Goldfarb
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CURB Curbline Properties | Maintains: Overweight | $28 → $31 | $24.36 | +27.26% | 2 | Feb 12, 2025 | |
LINE Lineage | Initiates: Overweight | $102 | $53.88 | +89.31% | 1 | Aug 19, 2024 | |
AVB AvalonBay Communities | Downgrades: Underweight | $189 → $160 | $218.92 | -26.91% | 1 | Nov 7, 2022 | |
ESS Essex Property Trust | Downgrades: Neutral | $297 → $250 | $294.74 | -15.18% | 1 | Oct 28, 2022 | |
BXP BXP, Inc. | Downgrades: Neutral | $120 → $100 | $68.86 | +45.22% | 1 | Jul 28, 2022 | |
EQR Equity Residential | Downgrades: Underweight | $78 → $70 | $71.56 | -2.18% | 1 | Jul 20, 2022 | |
NMRK Newmark Group | Downgrades: Neutral | $20 → $15 | $14.16 | +5.93% | 2 | Apr 18, 2022 | |
MAC The Macerich Company | Downgrades: Underweight | $18 → $14 | $19.82 | -29.36% | 5 | Apr 18, 2022 | |
UDR UDR, Inc. | Downgrades: Underweight | n/a | $42.83 | - | 1 | Jul 27, 2020 |
Curbline Properties
Feb 12, 2025
Maintains: Overweight
Price Target: $28 → $31
Current: $24.36
Upside: +27.26%
Lineage
Aug 19, 2024
Initiates: Overweight
Price Target: $102
Current: $53.88
Upside: +89.31%
AvalonBay Communities
Nov 7, 2022
Downgrades: Underweight
Price Target: $189 → $160
Current: $218.92
Upside: -26.91%
Essex Property Trust
Oct 28, 2022
Downgrades: Neutral
Price Target: $297 → $250
Current: $294.74
Upside: -15.18%
BXP, Inc.
Jul 28, 2022
Downgrades: Neutral
Price Target: $120 → $100
Current: $68.86
Upside: +45.22%
Equity Residential
Jul 20, 2022
Downgrades: Underweight
Price Target: $78 → $70
Current: $71.56
Upside: -2.18%
Newmark Group
Apr 18, 2022
Downgrades: Neutral
Price Target: $20 → $15
Current: $14.16
Upside: +5.93%
The Macerich Company
Apr 18, 2022
Downgrades: Underweight
Price Target: $18 → $14
Current: $19.82
Upside: -29.36%
UDR, Inc.
Jul 27, 2020
Downgrades: Underweight
Price Target: n/a
Current: $42.83
Upside: -